SEC Comment Letter 0000000000-24-006698 to Renalytix plc (RNLX, RTNXF) (CIK 0001811115) (RENXF)
Renalytix plc (RNLX, RTNXF) (CIK 0001811115)
Date: June 11, 2024 · CIK: 0001811115 · Accession: 0000000000-24-006698
AI Filing Summary & Sentiment
File numbers found in text: 333-279966
Letter
United States securities and exchange commission logo June 11, 2024 James McCullough Chief Executive Officer Renalytix plc 2 Leman Street London E1W 9US United Kingdom Re:Renalytix plc Registration Statement on Form S-3 Filed June 5, 2024 File No. 333-279966 Dear James McCullough: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Aja Eiden at 202-551-6072 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Marc Recht
Show Raw Text
United States securities and exchange commission logo
June 11, 2024
James McCullough
Chief Executive Officer
Renalytix plc
2 Leman Street
London E1W 9US
United Kingdom
Re:Renalytix plc
Registration Statement on Form S-3
Filed June 5, 2024
File No. 333-279966
Dear James McCullough:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Aja Eiden at 202-551-6072 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Marc Recht